Nephrocare Health Services Schedules Q3FY26 Earnings Call for Feb 11, 2026
Nephrocare Health Services Limited will hold its Q3FY26 Earnings Call on February 11, 2026, at 4:00 PM IST. The call will discuss unaudited financial results for the quarter and nine months ended December 31, 2025. Key management personnel will participate.
This is a routine announcement scheduling an earnings call. It does not contain any new financial information or strategic decisions that would immediately impact the company's stock price or operations.
The announcement is a routine schedule for an earnings call and does not contain any specific financial results or forward-looking guidance that would indicate a positive or negative sentiment.
Nephrocare Health Services Limited has announced the schedule for its Q3FY26 Earnings Call to discuss the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The call is scheduled for Wednesday, February 11, 2026, at 04:00 PM IST.
The company representatives participating in the call will include Mr. Vikram Vuppala (Chairman & Managing Director), Mr. Kamal Shah (Co-Founder), Mr. Rohit Singh (Group Chief Executive Officer), and Mr. Prashant Goenka (Group Chief Financial Officer). The teleconference will be moderated by Gaurav Tinani from Institutional Equities, Ambit Capital.
Details for joining the conference call have been provided, including primary access numbers and international toll-free numbers for various regions. Investors are encouraged to register via DiamondPass and dial in a few minutes prior to the scheduled time. The disclosure is also available on the company's website, www.nephroplus.com.
What to do with a filing like this
Nephrocare Health Services Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Nephrocare Health Services Limited. Read the original for the full detail.